Evolokumabs effekt och kostnadseffektivitet hos patienter utan familjär kolesterolemi.
Atherosclerosis is the underlying cause for many serious cardiovascular diseases which causes over 50 % of all deaths in Sweden. Atherosclerotic plaque builds up in the vessel walls over decades that will eventually lead to a complete block of an artery or cause thrombosis when the plaque ruptures,...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | Swedish |
| Published: |
Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB)
2019
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-85420 |